233 related articles for article (PubMed ID: 25026745)
21. Relationship between childhood obesity cut-offs and metabolic and vascular comorbidities: comparative analysis of three growth standards.
Martínez-Costa C; Núñez F; Montal A; Brines J
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():75-83. PubMed ID: 23808870
[TBL] [Abstract][Full Text] [Related]
22. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
[TBL] [Abstract][Full Text] [Related]
23. Interleukin Levels and Non-Alcoholic Fatty Liver Disease in Chronic Plaque Psoriasis: An Analytical Case Control Study.
Yadav V; Mendiratta V; Agrawal A; Bisherwal K; Singh R; Meena AK
Indian J Dermatol; 2023; 68(4):377-384. PubMed ID: 37822394
[TBL] [Abstract][Full Text] [Related]
24. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
[TBL] [Abstract][Full Text] [Related]
25. Role of serum uric acid in conditioning the association of psoriasis with metabolic syndrome.
Cassano N; Carbonara M; Panaro M; Vestita M; Vena GA
Eur J Dermatol; 2011; 21(5):808-9. PubMed ID: 21737375
[No Abstract] [Full Text] [Related]
26. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
[TBL] [Abstract][Full Text] [Related]
27. [C-reactive protein as a new risk factor of coronary heart disease in the population of young Polish males].
Olszewski R; Grabysa R; Warmiński J; Makowski T; Szczechowicz R; Piechota W; Adamus J
Pol Merkur Lekarski; 2002 Jul; 13(73):14-7. PubMed ID: 12362497
[TBL] [Abstract][Full Text] [Related]
28. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
Liang S; Hu Y; Liu C; Qi J; Li G
Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122
[TBL] [Abstract][Full Text] [Related]
29. [Situation of impaired glucose regulation and metabolic syndrome in overweight or obesity adolescent students in Dongguan city].
Peng YQ; Nie WM; Chen JG; Tang HM; Cao T; Lin YX
Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):495-500. PubMed ID: 19950716
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular risk factors in patients with chronic plaque psoriasis: a case-control study on the Brasov County population.
Irimie M; Oanţă A; Irimie CA; Fekete LG; Minea DI; Pascu A
Acta Dermatovenerol Croat; 2015; 23(1):28-35. PubMed ID: 25969910
[TBL] [Abstract][Full Text] [Related]
31. Comorbidities associated with psoriasis: an experience from the Middle East.
Al-Mutairi N; Al-Farag S; Al-Mutairi A; Al-Shiltawy M
J Dermatol; 2010 Feb; 37(2):146-55. PubMed ID: 20175849
[TBL] [Abstract][Full Text] [Related]
32. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
Amihăesei IC; Chelaru L
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
[TBL] [Abstract][Full Text] [Related]
33. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
Lepira FB; M'Buyamba-Kabangu JR; Kayembe KP; Nseka MN
Cardiovasc J S Afr; 2005; 16(5):249-55. PubMed ID: 16307156
[TBL] [Abstract][Full Text] [Related]
34. Atherosclerosis, some serum inflammatory markers in psoriasis.
Alpsoy S; Akyuz A; Erfan G; Akkoyun DC; Topcu B; Guzel S; Kaya S; Kulac M
G Ital Dermatol Venereol; 2014 Apr; 149(2):167-75. PubMed ID: 24819636
[TBL] [Abstract][Full Text] [Related]
35. Serum irisin levels in patients with psoriasis.
Baran A; Myśliwiec H; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2017 Jun; 28(4):304-308. PubMed ID: 27786588
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of the metabolic syndrome in children with psoriatic disease.
Goldminz AM; Buzney CD; Kim N; Au SC; Levine DE; Wang AC; Volf EM; Yaniv SS; Kerensky TA; Bhandarkar M; Dumont NM; Lizzul PF; Loo DS; Kulig JW; Brown ME; Lopez-Benitez JM; Miller LC; Gottlieb AB
Pediatr Dermatol; 2013; 30(6):700-5. PubMed ID: 24016334
[TBL] [Abstract][Full Text] [Related]
37. Determination of subclinical atherosclerosis in plaque type psoriasis patients without traditional risk factors for atherosclerosis.
Altekin ER; Koç S; Karakaş MS; Yanıkoğlu A; Başarıcı I; Demir I; Alpsoy E
Turk Kardiyol Dern Ars; 2012 Oct; 40(7):574-80. PubMed ID: 23363939
[TBL] [Abstract][Full Text] [Related]
38. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
39. Increased serum C-reactive protein level in Japanese patients of psoriasis with cardio- and cerebrovascular disease.
Takahashi H; Iinuma S; Honma M; Iizuka H
J Dermatol; 2014 Nov; 41(11):981-5. PubMed ID: 25291969
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of metabolic syndrome in patients with psoriasis.
Nisa N; Qazi MA
Indian J Dermatol Venereol Leprol; 2010; 76(6):662-5. PubMed ID: 21079309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
